By Staff
Monday, March 25, 2024 12:18 AM
SAN DIEGO—
Lenz Therapeutics, Inc., a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop that has been shown to improve near vision in people with presbyopia, has announced the completion of its previously announced merger with
Graphite Bio, Inc., a clinical-stage, gene editing company.
By Staff
Friday, March 15, 2024 12:24 AM
DALLAS—
Neurolens, based here, has announced a strategic leadership restructure. The new structure combines seasoned leadership with strategic hires. In December, company co-founder Davis Corley returned as CEO.
By Staff
Friday, February 16, 2024 12:21 AM
CHARENTON-LE-PONT, France—
EssilorLuxottica's board of directors has decided to propose the reappointment of all current directors to the next annual general meeting to be held on April 30, 2024.
By Staff
Monday, January 22, 2024 12:27 AM
NEW YORK—A leading futurist who will provide informed insights and data about the advent of Generative AI technology to business leaders, a noted expert's views about the fast-moving adoption of AI technology in the retail space, and a top global influencer discussing AI's role in branding and the consumer experience are three new speakers rounding out the program for the upcoming 2024 VM Leadership Summit, "What's Your AI Acuity? Sharpening a Vision for the Future," to be held March 13 here just prior to Vision Expo East.
By Staff
Wednesday, January 17, 2024 12:27 AM
RANCHO CORDOVA, Calif.—
VSP Vision has announced several organizational changes, noting a continued focus on growth and commitment to meeting the needs of clients members and network doctors. Scott Hopeck has been appointed to the new role of chief commercial officer (CCO), where he will lead commercial strategy, including supply chain sales and global business development, to drive value and improved customer experiences across the enterprise. Hopeck will provide end-to-end oversight of VSP Vision’s supply chain business operations while enhancing collaboration and prioritization, the company said.
By Staff
Tuesday, January 16, 2024 11:50 AM
CORAL SPRINGS, Fla.—
ABB Optical, a leader in the eyecare services industry, has announced the appointment of Daniel Liberman as chief executive officer, effective Feb. 1. Liberman will assume the role held by Tom Burke, who will become co-chairman of the board of directors. An announcement from ABB Optical stated, "During Tom Burke's five-year tenure as CEO, ABB has gone from the leading contact lens distributor to a full eyecare solutions platform offering ophthalmic laboratory services and practice optimization software."
By Staff
Friday, December 29, 2023 12:21 AM
NEW YORK—Early bird registration for VM's 2024 Leadership Summit program, an upcoming live event to be held in NYC on March 13, will expire on Dec. 31 at 11:59 p.m. ET. Details for registration and more about the speakers are posted at
www.visionmonday.com/summit. The speaker roster is growing for the VM Summit, which asks, "What's Your AI Acuity? Sharpening a Vision for the Future." The latest to join the exclusive annual event for senior executives and key opinion leaders in the vision care space is Dr. John Whyte, MD, MPH, who is
WebMD's chief medical officer and one of the most influential voices in the health sector.
By Staff
Wednesday, December 27, 2023 12:24 AM
NEW YORK—The speaker roster is growing for VM's 2024 Leadership Summit program, an upcoming live event to be held in NYC on March 13, which asks, "What's Your AI Acuity? Sharpening a Vision for the Future." The latest to join the exclusive annual event for senior executives and key opinion leaders in the vision care space is Dr. John Whyte, MD, MPH, who is
WebMD's chief medical officer and one of the most influential voices in the health sector.
By Staff
Wednesday, December 27, 2023 12:18 AM
PETALUMA, Calif.—
RetinalGeniX Technologies Inc., an ophthalmic research and development med-device and therapeutic drug development company, has announced that Anatoly Dritschilo, MD has joined the company’s medical advisory board.
By Staff
Wednesday, December 20, 2023 12:21 AM
MONTREAL—
EssilorLuxottica Canada has appointed industry veteran Bruce Miles as general manager, professional solutions for the Canadian market. Miles will be responsible for both the frame and lens business across the country.
By Staff
Thursday, December 14, 2023 12:21 AM
OBERKOCHEN, Germany—The supervisory board of
Carl Zeiss AG has appointed Stefan Müller the new chief financial officer (CFO) of Carl Zeiss AG, effective Jan. 1, 2024.
By Staff
Wednesday, December 13, 2023 12:21 AM
ATLANTA—
Alimera Sciences, Inc., a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announced the appointment of Todd Wood as president of U.S. operations, effective immediately.
By Staff
Thursday, December 7, 2023 12:18 AM
ISELIN, N.J.—
Outlook Therapeutics, Inc., a biopharmaceutical company working to achieve U.S. Food and Drug Administration approval for the first ophthalmic formulation of bevacizumab for the treatment of retinal diseases, announced a realignment of resources.
By Staff
Wednesday, December 6, 2023 12:15 AM
LAKE FOREST, Calif.—
STAAR Surgical Company, a leading developer, manufacturer and marketer of the EVO family of implantable collamer lenses for myopia, astigmatism and presbyopia, announced the appointment of Lilian Zhou to its board of directors.
By Staff
Tuesday, December 5, 2023 12:15 AM
SAN RAMON, Calif.—
CooperCompanies announced that its board of directors has appointed Lawrence E. Kurzius as an independent director, effective Dec. 1, 2023.